Aspect Medical Systems competitors

A Strategic and Operational CFO with broad & deep geographic and business experience in Pharmaceutical, Biotech, Medical Device & Consumer Goods leading international markets worldwide in Financial operations, General Management, Information Technology, Procurement & Facilities. A strategic thinker partnering with leadership to develop long-range plans and deliver business & financial results through fact-based decision support, developing diverse cross-functional talent and implementing comprehensive metrics. Identify and sponsor change through P&L efficiencies, improved cash flow and new business models, fueling profit growth and margin expansion. Appling this approach to lead “beyond the numbers” with broad business acumen to impact the business.Recognized as a thought leader and business partner with a hands-on approach going beyond the financial leader role, a strong communicator who sorts through complexity and asks the right questions, willing to challenge the status quo & lead transformational change. Develop global finance organizations, placing leaders beyond the finance function.Experienced Management Board member of various sized healthcare, life science and consumer goods companies from start-up to multi-billion dollar global market leaders, driving high-growth businesses, improving turn-arounds and acquisition integration. Led financial organizations from 5 to 200 employees.Areas of expertise:Growth Strategies | Global Leadership | Board Member | Fact-Based Decision Support | Strategic & Financial Planning | Worldwide P&L Management | International Finance | Cost Accounting | Competitive Intelligence | Talent DevelopmentAdditional skills:Internal Financial Controls | Financial & Portfolio Analysis | Tax Planning | International Treasury Functions | Capital Structure & Cash Management | Mergers & Acquisition | Project Management | Investor Relations | New Product Launches | Acquisition Integration

Jim Green is Chairman, President and CEO of Harvard Bioscience (NASDAQ: HBIO). With a tract record of successful turn-a-rounds Green was named operating President and CEO in July 2019 by the Board and tasked to create substantial shareholder value through the fundamentals by turning the company into a profitable growth oriented platform. Green served as President and CEO of Analogic Corporation (NASDAQ: ALOG) from 2007 to 2016. While leading Analogic through the great recession, Analogic’s core revenues grew over 50%, and gross margins, operating margins and earnings per share dramatically improved. Immediately prior to becoming President and CEO of Harvard Bioscience, Green served as President of Spacelabs Healthcare, where he led a successful global restructuring, rationalizing the company’s cost structure and product portfolio and quickly stabilized the business, with revenues returning to organic growth while significantly improving gross and operating margins with operating profit improving over 50%.

Healthcare business executive with broad experience in product development, global marketing, commercialization and sales of medical devices. Strong background in market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization. Specialty experience working with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, business development and strategy development including strategic planning and acquisitions.

Takaaki Ueda is a Chairman/CEO at SONOSITE INC, Pres & CEO:New Development USA at Fujifilm Holdings, and President/CEO at FUJIFILM Medical Systems USA Inc. He has worked as Gen Mgr:Global Endoscopy Systems at Fujifilm Holdings.

Ms. Jacqueline Eastwood is a Founder, President and Chief Executive Officer at Salient Surgical Technologies and is based in United States.